Roberts Eiry's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Dec 11, 2023
- Accession no.
- 0001209191-23-058116
- Filed
- Dec 11, 2023
- Trade date
- Dec 7-8, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 6 derivative transactions. Open-market sales total $9.35M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts EiryCIK 0001727606 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +38,722 | $77.81 | +$3,012,958.82 | 68,243 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −38,722 | $120.37 | −$4,660,967.14 | 29,521 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +12,742 | $77.81 | +$991,455.02 | 42,263 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −12,742 | $120.37 | −$1,533,754.54 | 29,521 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +14,140 | $79.02 | +$1,117,342.8 | 43,661 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −14,140 | $120.37 | −$1,702,031.8 | 29,521 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseAcquired | +11,775 | $81.05 | +$954,363.75 | 41,296 | Direct | |
| Dec 7, 2023 | Common Stock | SSaleDisposed | −11,775 | $120.37 | −$1,417,356.75 | 29,521 | Direct | |
| Dec 8, 2023 | Common Stock | MOption exerciseAcquired | +200 | $81.05 | +$16,210 | 29,721 | Direct | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −200 | $120.16 | −$24,032 | 29,521 | Direct | |
| Dec 8, 2023 | Common Stock | MOption exerciseAcquired | +100 | $81.05 | +$8,105 | 29,621 | Direct | |
| Dec 8, 2023 | Common Stock | SSaleDisposed | −100 | $120.00 | −$12,000 | 29,521 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −38,722 | $77.81 | −$3,012,958.82 | 12,742 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −12,742 | $77.81 | −$991,455.02 | 0 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −14,140 | $79.02 | −$1,117,342.8 | 60,005 | Direct | |
| Dec 7, 2023 | Common Stock | MOption exerciseDisposed | −11,775 | $81.05 | −$954,363.75 | 53,665 | Direct | |
| Dec 8, 2023 | Common Stock | MOption exerciseDisposed | −200 | $81.05 | −$16,210 | 53,465 | Direct | |
| Dec 8, 2023 | Common Stock | MOption exerciseDisposed | −100 | $81.05 | −$8,105 | 53,365 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.